Does local injection of reveromycin A inhibit tooth movement without causing systemic side effects?

Area of Science:

• Orthodontics
• Pharmacology
• Skeletal Biology

Background:

• Experimental tooth movement involves complex biological processes including osteoclast-mediated bone resorption.
• Controlling these biological processes locally could enhance orthodontic treatment efficiency and predictability.

Purpose of the Study:

• To assess the feasibility of using local intraoral reveromycin A (RMA) injections to inhibit osteoclast activity and control experimental tooth movement in mice.
• To evaluate potential systemic side effects of local RMA administration.

Main Methods:

• Eight-week-old wild-type mice received local intraoral injections of RMA or saline twice daily for 14 or 21 days.
• A Ni-Ti closed coil spring was used to induce tooth movement.
• Tooth movement distance, alveolar bone changes (bone surface area ratio, osteoclast counts), and systemic effects (tibial bone analysis) were evaluated.

Main Results:

• Local RMA injection significantly inhibited tooth movement by 40.6% and promoted alveolar bone volume maintenance by 37.4% at 21 days.
• Osteoclast activity around the tooth root was reduced by 40.8% with local RMA treatment.
• No systemic side effects on osteoclasts or osteoblasts were observed in the tibial bone.

Conclusions:

• Local intraoral administration of reveromycin A is a feasible strategy for controlling experimental tooth movement in a mouse model.
• RMA effectively inhibited osteoclast activity and tooth movement without inducing observable systemic adverse effects.